The Cigna Group (CI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,778,000 | 5,372,000 | 6,782,000 | 5,420,000 | 8,489,000 |
| Depreciation Amortization | 2,775,000 | 3,035,000 | 2,937,000 | 2,923,000 | 2,802,000 |
| Income taxes - deferred | -95,000 | -1,659,000 | -472,000 | -216,000 | -386,000 |
| Accounts payable and accrued liabilities | 9,895,000 | 5,511,000 | 3,494,000 | 2,038,000 | 4,237,000 |
| Other Working Capital | 1,192,000 | 3,488,000 | 584,000 | -879,000 | 3,598,000 |
| Other Operating Activity | -7,182,000 | -3,934,000 | -4,669,000 | -2,095,000 | -8,390,000 |
| Operating Cash Flow | $10,363,000 | $11,813,000 | $8,656,000 | $7,191,000 | $10,350,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,406,000 | -1,573,000 | -1,295,000 | -1,154,000 | -1,094,000 |
| Net Acquisitions | 390,000 | -434,000 | 4,835,000 | -1,894,000 | 5,453,000 |
| Purchase Of Investment | -2,749,000 | -5,657,000 | -4,480,000 | -6,434,000 | -6,802,000 |
| Sale Of Investment | 2,635,000 | 2,822,000 | 4,208,000 | 5,774,000 | 5,396,000 |
| Other Investing Activity | -972,000 | -332,000 | -170,000 | 97,000 | 23,000 |
| Investing Cash Flow | $-2,102,000 | $-5,174,000 | $3,098,000 | $-3,611,000 | $2,976,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -402,000 | 1,198,000 | -2,059,000 | 975,000 | 60,000 |
| Debt Issued | 4,462,000 | 1,491,000 | 0 | 4,260,000 | 4,863,000 |
| Debt Repayment | -3,000,000 | -2,967,000 | -500,000 | -4,714,000 | -9,659,000 |
| Common Stock Issued | 305,000 | 187,000 | 389,000 | 326,000 | 376,000 |
| Common Stock Repurchased | -7,034,000 | -2,284,000 | -7,607,000 | -7,742,000 | -4,042,000 |
| Dividend Paid | -1,567,000 | -1,450,000 | -1,384,000 | -1,341,000 | -15,000 |
| Other Financing Activity | -411,000 | -469,000 | -79,000 | 24,000 | -116,000 |
| Financing Cash Flow | $-7,647,000 | $-4,294,000 | $-11,240,000 | $-8,212,000 | $-8,533,000 |
| Exchange Rate Effect | -20,000 | 16,000 | -86,000 | -65,000 | 41,000 |
| Beginning Cash Position | 8,337,000 | 5,976,000 | 5,548,000 | 10,245,000 | 5,411,000 |
| End Cash Position | 8,931,000 | 8,337,000 | 5,976,000 | 5,548,000 | 10,245,000 |
| Net Cash Flow | $594,000 | $2,361,000 | $428,000 | $-4,697,000 | $4,834,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,363,000 | 11,813,000 | 8,656,000 | 7,191,000 | 10,350,000 |
| Capital Expenditure | -1,406,000 | -1,573,000 | -1,295,000 | -1,154,000 | -1,094,000 |
| Free Cash Flow | 8,957,000 | 10,240,000 | 7,361,000 | 6,037,000 | 9,256,000 |